Did you dispense insulin pens? If so, we want to hear from you! We are attorneys investigating reports of a “don’t break the box” policy.**
The “don’t break the box” policy
Each patient uses a different amount of insulin and thus needs a different number of insulin pens per prescription. Insulin pens, such as Lantus, come in boxes with 5 pens each. To decide how many insulin pens to give to a patient for 30 days (the typical period for Medicare / Medicaid prescriptions), pharmacy techs should calculate the “day’s supply” for each patient. By calculating “day’s supply,” pharmacists determine the number of insulin units and pens to last a patient the length of their prescription period. A “don’t break the box” policy means that dispensing records are altered when excess pens are dispensed.
Yet, at Walmart, we believe that pharmacy employees were instructed not to “break the box” of insulin pens without regard to “day’s supply” calculations. A “don’t break the box” policy means dispensing more pens than a prescription requires and in turn costing the government more to provide their beneficiaries with the insulin they actually need.
We need to hear from you to make this right!
If you witnessed the “don’t break the box” policy in action and you are a former Walmart pharmacy employee, please describe your experience in our contact form below. Please list the location of the Walmart stores where you worked and your experience distributing insulin pens. If you are willing to talk about your experience in more detail, please provide us with your email and phone number.
The information you provide may contribute to reducing Taxpayer medical expenses, and for that, we say a big THANK YOU!
** Please do not contact us if you are a current Walmart employee or if you have been in contact with Walmart lawyers. We are seeking information, not soliciting clients. **